Claims for Patent: 5,695,968
✉ Email this page to a colleague
Summary for Patent: 5,695,968
Title: | Process for production of D-.alpha.-amino acids |
Abstract: | The present invention is directed to a gene which is related to a D-N-carbamoyl-.alpha.-amino acid amidohydrolase which is an enzyme capable of converting D-N-carbamoyl-.alpha.-amino acids into D-.alpha.-amino acids; a recombinant plasmid in which a DNA fragment containing the gene is incorporated into a vector; a microorganism belonging to the genus Escherichia, Pseudomonas, Flavobacterium, Bacillus, Serratia, Corynebacterium, or Brevibacterium, which is transformed by incorporating the recombinant plasmid thereinto; a process for the production of D-N-carbamoyl-.alpha.-amino acid amidohydrolases, comprising the steps of cultivating the transformed microorganism and collecting the desired product therefrom; a D-N-carbamoyl-.alpha.-amino acid amidohydrolase obtained by the method; and a process for the production of D-.alpha.-amino acids with the aid of an action of the enzyme. The D-N-carbamoyl-.alpha.-amino acid amidohydrolase can be fixed on a support for immobilization and used as an immobilized enzyme. |
Inventor(s): | Nanba; Hirokazu (Takasago, JP), Yamada; Yukio (Kakogawa, JP), Takano; Masayuki (Akashi, JP), Ikenaka; Yasuhiro (Akashi, JP), Takahashi; Satomi (Kobe, JP), Yajima; Kazuyoshi (Kobe, JP) |
Assignee: | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha (Osaka, JP) |
Application Number: | 08/479,638 |
Patent Claims: | 1. A process for the production of D-.alpha.-amino acids characterized in that D-N-carbamoyl-.alpha.-amino acids represented by the formula:
R--CH(NHCONH.sub.2)--COOH wherein R is phenyl; phenyl substituted with hydroxy; alkyl having 1 to 4 carbon atoms; alkyl having 1 to 4 carbon atoms substituted with hydroxy, alkylthio, carboxyl, amino, phenyl or phenyl substituted with hydroxy or amido; aralkyl having 7 to 8 carbon atoms; or thienyl; provided that when R is phenyl substituted with hydroxyl, optionally one or more hydroxyl groups are attached at any of the o-, m-, and p-positions; are converted into the corresponding D-.alpha.-amino acids in an aqueous medium, using an enzyme which is produced by a transformant obtained by transforming a host bacterial cell with a recombinant DNA comprising a vector and a DNA fragment having a gene encoding said enzyme, said enzyme being capable of converting D-N-carbamoyl-.alpha.-amino acids by removal of their carbamoyl groups into the corresponding D-.alpha.-amino acids, after which the D-.alpha.-amino acids are collected, wherein the recombinate DNA is a plasmid selected from the group consisting of pAHD 101, pAD 108, pPHD 301, and pPD 304. 2. A process for the production of D-.alpha.-amino acids characterized in that D-N-carbamoyl-.alpha.-amino acids represented by the formula: R--CH(NHCONH.sub.2)--COOH wherein R is phenyl; phenyl substituted with hydroxy; alkyl having 1 to 4 carbon atoms; alkyl having 1 to 4 carbon atoms substituted with hydroxy, alkylthio, carboxyl, amino, phenyl or phenyl substituted with hydroxy or amido; aralkyl having 7 to 8 carbon atoms; or thienyl; provided that when R is phenyl substituted with hydroxyl, one or more hydroxyl groups are attached at any of the o-, m-, and p-positions; are converted into the corresponding D-.alpha.-amino acids in an aqueous medium, using an enzyme which is produced by a transformant obtained by transforming a host bacterial cell with a recombinant DNA comprising a vector and a DNA fragment having a gene encoding a D-N-carbamoyl-.alpha.-amino acid amidohydrolase capable of converting D-N-carbamoyl-.alpha.-amino acids by removal of their carbamoyl groups into the corresponding D-.alpha.-amino acids, after which the D-.alpha.-amino acids are collected, wherein said transformant is selected from the group consisting of Escherichia coli JM 109 pAHD 101, Escherichia coli JM 109 pAD 108 (FERM BP-3184), Escherichia coli JM 109 pPHD 301 and Escherichia coli JM 109 pPD 304 (FERM BP-3183). 3. A process for the production of a D-.alpha.-amino acids characterized in that D-N-carbamoyl-.alpha.-amino acids represented by the formula: wherein R is phenyl; phenyl substituted with hydroxy; alkyl having 1 to 4 carbon atoms; alkyl having 1 to 4 carbon atoms substituted with hydroxy, alkylthio, carboxyl, amino, phenyl or phenyl substituted with hydroxy or amido; aralkyl having 7 to 8 carbon atoms; or thienyl; provided that when R is phenyl substituted with hydroxyl, optionally one or more hydroxyl groups are attached at any of the o-, m-, and p-positions; are converted into the corresponding D-.alpha.-amino acids in an aqueous medium, using an enzyme which is produced by a bacterium selected from the group consisting of Pseudomonas sp. KNK 0030A (FERM BP-3181), and Pseudomonas sp. KNK 505 (FERM BP-3182), said enzyme being capable of converting D-N-carbamoyl-.alpha.-amino acids by removal of their carbamoyl groups into the corresponding D-.alpha.-amino acids, after which the D-.alpha.-amino acids are collected. |
Details for Patent 5,695,968
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Baxalta Us Inc. | BIOCLATE (ARMOUR), RECOMBINATE | antihemophilic factor (recombinant) | For Injection | 103375 | 12/10/1992 | ⤷ Try a Trial | 2014-12-09 |
Baxalta Us Inc. | BIOCLATE (ARMOUR), RECOMBINATE | antihemophilic factor (recombinant) | For Injection | 103375 | 03/10/2010 | ⤷ Try a Trial | 2014-12-09 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.